Source: ampersandcapital.com

Ampersand acquired Nektar Therapeutics’ PEG Reagent Manufacturing Business for undisclosed amount

Read full article »
Ampersand's Competitors | Ampersand's News | Ampersand's Financials
Stay up-to-date with the latest news on Ampersand
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Herb H. Hooper's photo - Managing Partner of Ampersand

Managing Partner

Herb H. Hooper

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Ampersand